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Background
Overexpression of microRNA-31 (miR-31) is implicated in the pathogenesis of esophageal squamous cell carcinoma (ESCC), a deadly disease associated with dietary zinc-deficiency. Using a rat model that recapitulates features of human ESCC, the mechanism whereby Zn regulates miR-31 expression to promote ESCC is examined.
Methods
To inhibit in vivo esophageal miR-31 overexpression in Zn-deficient rats (n = 12-20 per group), locked-nucleic-acid modified anti-miR-31 oligonucleotides were administered over 5-weeks. miR-31 expression was determined by northern blotting, qPCR, and in situ hybridization.
Physiological miR-31 targets were identified by microarray analysis and verified by luciferase reporter assay. Cellular proliferation, apoptosis, and expression of inflammation genes were determined by immunoblotting, caspase assays, and immunohistochemistry. The miR-31 promoter in Zn-deficient esophagus was identified by ChIPseq using an antibody for histone mark H3K4me3. Data were analyzed with t-test and ANOVA. All statistical tests were two-sided.
Results
In vivo, anti-miR-31 reduced miR-31 overexpression (P =.002) and suppressed the esophageal preneoplasia in Zn-deficient rats. At the same time, the miR-31 target Stk40 was derepressed, thereby inhibiting the STK40-NF-kB controlled inflammatory pathway, with resultant decreased cellular proliferation and activated apoptosis (caspase 3/7 activities, fold change = 10.7, P = .005)..
Introduction
Esophageal squamous cell carcinoma (ESCC) is a major cause of cancer death worldwide (1) .
Due to lack of early symptoms, ESCC is typically diagnosed at an advanced stage, and only 10% of patients survive 5-years. Thus, clarification of the mechanisms underlying the pathogenesis of ESCC and development of new prevention and therapeutic strategies are urgently needed.
MicroRNAs (miRNAs) are short, non-coding RNAs that regulate gene expression by means of translational inhibition and mRNA degradation (2) . Each miRNA has the ability to inhibit multiple target genes or entire signaling pathways, regulating a range of biological processes, including cell proliferation, differentiation, and apoptosis. MiRNA expression levels are altered in all human cancers studied (3) . MiRNAs can act as oncogenes or tumor suppressors (4, 5) and have emerged as therapeutic targets for cancer (6) . The challenge is to identify their protein targets and determine how these protein targets contribute to tumor initiation and progression.
Risk factors for ESCC include alcohol and tobacco use and known nutritional factors such as
Zn-deficiency (7). Our well-characterized Zn-deficient (ZD) rat esophageal cancer model reproduces the ZD (7) and inflammation feature of human ESCC (8) and is exquisitely sensitive to esophageal tumorigenesis by environmental carcinogens (9, 10) . We have previously shown that rats on a ZD diet for 5 weeks develop hyperplastic esophagi with a distinct gene signature that includes upregulation of the proinflammation mediators S100a8/a9 (11) . Prolonged ZD (23 weeks) leads to an expanded cancer-associated inflammatory program (10) and induction of an oncogenic miRNA signature with miR-31 as the top upregulated species (12) , as also observed in human ESCCs (13, 14) . miR-31 is among the most frequently dysregulated microRNAs in human cancers (15) .
Depending on tumor type, miR-31 can be up-or downregulated, thus exhibiting oncogenic or tumor suppressive roles in cancers. Notably, miR-31 is overexpressed and oncogenic in colorectal cancer (16) , lung cancer (17) , and squamous cell carcinomas (SCCs), including ESCC (13, 14) , tongue SCC (18), head and neck SCC (19) , and skin SCC (20) , but it is downregulated in serous 5 ovarian cancer (21) . , The mechanisms by which miR-31 upregulation contributes to ESCC initiation and progression are not understood. In the present study, the biological functions of miR-31 in esophageal neoplasia and the mechanism whereby Zn regulates miR-31 expression to promote ESCC were examined.
Methods
Animals Studies
Animal protocols were approved by the Thomas Jefferson University Animal Care and Use Committee. Weanling male Sprague-Dawley rats were from Taconic Laboratory. Customformulated ZD and ZS diets (Harlan Teklad, Madison, WI) were identical except for the amount of zinc, which was 3-4 ppm for ZD and 60 ppm for ZS diet. Further details on animal studies, tissue isolation; RNA preparation; RT-QPCR; TaqMan miRNA assay; enzyme-linked immunosorbent assay; western blot, northern blot, caspase, luciferase, cell proliferation, and electrophoretic mobility shift assays; in situ hybridization (ISH); immunohistochemistry; and serum Zn measurement are in Supplementary Methods, available online.
Locked-Nucleic Acid (LNA)-Modified Oligonucleotides
Custom unlabeled and phosphothioated LNA TM anti-rno-miR-31 oligonucleotide (5'-CAGCTATGCCAGCATCTTGCCT-3', complementary to nucleotides 1-22 in the mature miR-31 sequence) and control rno-miR-31 scrambled oligonucleotide (5'-GTGTAACACGTCTATACGCCCA-3') were obtained from Exiqon (Vedbaek, Denmark). 
Human ESCC Samples and Cell Lines
Peak Calling and Data Analysis
Details are given in Supplementary Methods. Briefly, the collection of aligned reads were filtered to remove artifacts and mapped to the rat genome (rn4) using the Bowtie (23) algorithm. The number of uniquely mapped monoclonal reads for each ChIP-seq group is shown in Supplementary Table 4 . To identify enriched regions of histone modifications ChIP-seq data, peak calling was performed using 0 algorithm (24) .
MOTIF-Finding and Quality Control
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To find TFBs, we used rat genome (rn4) and Jaspar (25) and TRANSFAC database (26) .
Further details are given in Supplementary Methods.
Statistical Analysis
Values are expressed as mean ± standard deviation. The Student t-test was used to detect differences in comparisons involving only 2 groups. Data between the 4 subject groups were analyzed by analysis of variance. For some variables (caspase, NF-kB p65 and miR-31 levels), a logarithmic transformation was performed to minimize the effects of heteroscedasticity.
Differences among the groups were assessed using the Tukey-HSD post hoc t-test for multiple comparisons. Statistical tests were two-sided and were considered significant at P< .05.
Statistical analysis was performed using R (http://www.R-project.org).
Results
Establishment of a Rat Esophageal Neoplasia Model Overexpressing miR-31
Previously (12) Figure 1A ) and northern analyses ( Figure 1B ), using RNA samples from ZD and ZS esophagus (n=8 rats per group). Using the same RNA assessment methods, we found that 5 weeks after ZD rats were switched to a ZS diet, the ZD-induced miR-31 overexpression was returned to normal ZS level (ZR/5wk rats; Figure 1 , A and B). Thus, miR-31 expression is responsive to Zn treatment, establishing a short-term ZD esophageal preneoplasia model for study of effects of miR-31 overexpression and silencing.
In Vivo Anti-miR-31 Delivery in Zn-Deficient Rat Esophageal Preneoplasia Model LNA-modified oligonucleotides are a class of RNA that exhibits in vivo high biostability, low toxicity, and adequate biodistribution (28) . LNA-anti-miR-122 oligos were shown to mediate effective in vivo inhibition of liver-expressed miR-122 function in rodents (29) and nonhuman primates (30) . In a phase 2a clinical trial to treat patients with hepatitis C virus (HCV) infection, miravirsen (an LNA-modified inhibitor of miR-122) showed dose-dependent reductions in HCV RNA levels, thus demonstrating a therapeutic effect by targeting a host miRNA (31) .
To inhibit esophageal miR-31 expression in vivo in Zn-deficient rats, we used LNA-anti-miR-31
oligonucleotide (complementary to nt 1-22 in the mature miR-31 sequence, hereafter called antimiR). As depicted in Figure 1C , male weanling rats received a ZD or ZS diet and were randomized into 4 groups: ZD/anti-miR, ZD/LNA-scrambled, ZD/saline, and ZS/saline. The animals received 10 doses of anti-miR, scrambled oligos, or saline, over a period of 5-weeks. During the 5-week study, the growth rate of all ZD groups was comparable to pair-fed ZS rats ( Figure 1E ). Regardless of treatment, serum Zn level in the three ZD groups was similar (~50 μg/100 ml), but lower than in ZS rats (P < .001, Figure 1D ).
After 5 weeks of ZD diet, qPCR analysis ( Figure 1F ) showed that ZD controls had markedly higher miR-31 levels in esophagus, tongue, and circulating blood (P = .009 to < .001) than the ZS counterpart, a result consistent with long-term ZD (23 weeks Macroscopically, anti-miR treated ZD esophageal epithelia were strikingly less swollen than control ZD esophagi. Histologically, the ZD/anti-miR cohort showed a markedly thinned epithelium with fewer cell layers than the hyperplastic ZD/scrambled cohort ( Figure 3A ). These findings demonstrate that miR-31 inhibition prevented the development of a hyperplastic esophageal phenotype in rats in spite of their ZD diet.
In addition to the esophagus, anti-miR-31 treatment prevented the development of a ZDinduced hyperplastic tongue epithelium (32) , as evidenced by a thinned epithelium ( Figure 2B ).
Moreover, throughout the 5-week study period, anti-miR-treated ZD rats showed a near normal hair coat while ZD/saline or ZD/scrambled rats typically developed a poor coat with alopecia.
Because ZD induces miR-31 expression in squamous skin associated with an inflammatory phenotype (12), it is likely that the improved skin phenotype in ZD rats was due to inhibition of miR-31 by anti-miR in skin, as in esophagus, tongue, and blood ( Figure 1F ).
miR-31 Antagonism and Esophageal Cellular Proliferation and Apoptosis
To assess esophageal cellular proliferation, we employed the proliferative marker PCNA.
Immunohistochemical (IHC) analysis showed that the cell proliferation index (% of intensely stained PCNA-positive nuclei, expressed as mean ± standard deviation, n=10 samples/group) in the ZD/anti-miR esophagus (27±5.1%) was markedly reduced (P < .001) relative to control ZD/saline (48±7.3%) or ZD/scrambled esophagus (47±4.2%) ( Figure 3B ). Similarly, immunoblot analysis showed reduced PCNA expression in ZD/anti-miR esophagi ( Figure 3C ) as well as in ZD/anti-miR tongue ( Figure 2C ) relative to ZD controls. Thus, miR-31 inhibition led to prominently decreased cellular proliferation.
To assess apoptosis induction, a luciferase-based chemical assay was used. ZD/anti-miR esophagus showed statistically significantly higher caspase 3/7 (P = .005, fold change = 10.7) and caspase 9 activities (P = .019, fold change = 3.8) than ZD/saline esophagus ( Figure 3D ), indicating that miR-31 inhibition induced apoptosis. Together, the data indicate that miR-31 inhibition suppresses the hyperplastic ZD esophageal phenotype via reduction of cell proliferation and activation of apoptosis.
Identification of Physiological miR-31 Targets in Esophageal Neoplasia
To identify genes with altered transcript levels in response to miR-31 silencing in vivo, we performed genome-wide expression profiling of esophageal mucosa from the 4 animal groups at 2.0 GeneChip (n=5 rats/treatment group). Hierarchical clustering of mRNA profiles revealed that the expression pattern in ZD/anti-miR esophagus was different from the control ZD/scrambled and ZD/saline esophagus, which were similar but distinct from ZS/saline esophagus ( Figure 3E ), implying that a large pool of the upregulated mRNAs in ZD/anti-miR RNAs correspond to derepressed miR-31 targets (29) . Analysis of the array data revealed that the list of derepressed genes in ZD/anti-miR vs ZD/saline esophagus and in ZD/anti-miR vs ZD/scrambled esophagus were similar. In addition, the list of differentially expressed genes were similar in ZD/scrambled vs ZS/saline and in ZD/saline vs ZS/saline, indicating that LNA/scrambled had little effect on gene expression. Guided by miR-31 target prediction bioinformatics, 13 derepressed genes ( Figure 3F) were chosen from the intersection analysis between a joint set of genes from ZD vs ZS rats and that from ZD vs ZD/anti-miR group. To validate this prediction, qPCR analysis was performed ( Figure 3G ). Of the 10 genes that showed derepression with anti-miR treatment, six genes, including Stk40 (P < .001), Cpm (P = .02), Acta2 (P = .02), Ces1d (P = .004),
Ly6e (P = .01), and Sft2d2 (P = .03) achieved a statistically significant difference between ZD/antimiR and ZD controls ( Figure 3G ), thereby validating the bioinformatics prediction ( Figure 3F ) that such genes would be derepressed after miR-31 silencing.
Stk40 (33, 34) and Cpm (35) are of particular interest because of their roles in inflammation.
We then determined if miR-31 directly interacts with Stk40 3'UTR by cotransfecting a pGL3 3¢ UTR luciferase reporter vector with synthetic miR-31 ( Figure 4 , A-C). A two-fold decrease in luciferase activity was observed, indicating a direct interaction between the miRNA and Stk40 3¢ UTR. Target gene repression was rescued by deletions in the complementary seed sites (fold change = 1.7, Figure 4C ). These data establish that Stk40, a known negative regulator of NF-kB mediated transcription (33) , is a miR-31 direct target. The regulation of Stk40 by miR-31 has been reported in ovarian cancer cells (21) and primary keratinocytes in psoriasis (34) . Additionally, we demonstrated that the Cpm 3' UTR is a miR-31 direct target by using the 3¢ UTR luciferase reporter assay ( Figure 5A ). We showed by western blot that CPM protein was downregulated in hyperplastic ZD esophagus that overexpresses miR-31, and was restored upon miR-31 inhibition ( Figure 5B ). Although CPM has emerged as a potential cancer biomarker (35) , the mechanism by which CPM contributes to carcinogenesis remains to be determined.
Anti-miR-31 Effects on STK40-NF-kB Based Inflammatory Pathway
We next focused our study on Stk40 because of its role in regulation of NF-kB (33), a key mediator of inflammation (36) . The ZD-induced esophageal preneoplasia is accompanied by cytoplasmic NF-kB p65 overexpression and nuclear translocation of NF-kB phospho-p65 (37) . We showed by enzyme-linked immunosorbent assay (ELISA) that miR-31 inhibition led to statistically significantly lower NF-kB p65 levels in ZD/anti-miR esophageal lysates as compared with control ZD lysates (P = .002, fold change = -2.8, Figure 4E ), a result confirming that miR-31 inhibition suppresses NF-kB activity (34) . To determine whether a connection occurs among miR-31, STK40, and downstream NF-kB signaling in esophageal neoplasia, we performed in situ detection of miR-31 expression combined with IHC analysis of the NF-kB p65-RAGE-S100A9 pathway (11), using FFPE esophageal tissues. In hyperplastic ZD/scrambled esophagus ( Figure 4F ), miR-31 overexpression was associated with downregulation of STK40 protein and accompanying upregulation of the NFkB p65-RAGE-S100A9 inflammatory pathway. Remarkably, in vivo anti-miR-31 delivery reduced miR-31 expression, upregulated STK40 protein expression, and abolished this NF-kB p65-RAGE inflammation network, resulting in a non-inflammatory esophageal phenotype that resembles the Zn-sufficient esophagus ( Figure 4F ). These in vivo findings show for the first time the important connections between oncomiR-31, STK40, and NF-kB p65-controlled signaling in esophageal neoplasia.
Cellular Localization of miR-31 Expression in Human ESCC Tissue
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Overexpression of miR-31 and STK40 and NF-kB Expression in Human ESCC Cells
To define the role of STK40 in human ESCC cells, we analyzed cell proliferation and apoptosis after STK40 silencing. STK40 silencing, as shown by western blot, decreased caspase 3/7 activity (P = .015) and increased viability of esophageal cancer cells (P = .03) ( Figure 4D ). These results are consistent with the cell proliferation ( Figure 3B ) and apoptosis ( Figure 3D 
Activation of miR-31 Promoter Region in Zn-Deficient Esophagus
Finally, to elucidate the mechanisms by which miR-31 is upregulated by Zn-deficiency, we To identify enriched regions of histone modifications in ChIP-seq data, we performed peakcalling analysis using SICER algorithm (24) (Supplementary Methods). By analyzing the genome occupancy of H3K4me3, we identified a promoter region ~30 kb (kilobases) upstream of the mature sequence location of miR-31 ( Figure 7A ). We used Integrative Genomics Viewer (IGV) (39) to visualize the promoter region of miR-31. H3K4me3 binding signals were statistically significantly enriched in ZD vs ZS esophagus (P < .001, Figure 7B ), indicating that the promoter is activated in ZD esophagus. With Zn-replenishment, H3K4me3 levels were significantly reduced (ZD vs ZS = 2.58 as compared to ZR vs ZS=1.52, Figure 7B ), accompanied by a near normal miR-31 level (northern blot, Figure 1B and ISH, Figure 7C ) and esophageal phenotype ( Figure 7C Table 3 ).
This miR-31 promoter region is conserved in humans and rats (Supplementary Figure 1) . To test the presence of putative cis-regulatory elements (promoters, enhancers) in human, we used public ChIP-seq data of several human cell lines and identified binding sites of PolII in the CpG island corresponding to rat island 77. Using chromatin state dynamics from ENCODE chromatic portal (40), we determined that this region is characterized by the presence of poised or active promoters (Supplementary Figure 1A) . Because a genome map of cis-regulatory elements is not available in rat genome, we used Blat, the University of California, Santa Cruz (UCSC) Genome
Browser (41) to find a conserved region in rats similar to CpG island 77. Using Blat (Supplementary Methods), we found a region with 85.2% similarity with humans. This region is indeed the promoter region that we have identified in rats (ChIP-seq data, Supplementary Figure   1B ).
Identification of RelA and Sp1 in miR-31 Promoter Region
We downloaded the DNA sequence from the rat genome (rn4) located at chr5: 108.520.153-108.537.803 that showed the highest continuous peak enriched in ZD esophagus for chromatin mark H3K4me3. To find the Transcription Factor Binding Site (TFBs), we used Jaspar Core (25) and TRANSFAC database (26) Figure 7A ). The TFBs for rat NFkB p65 (subunit of NF-kB transcription factor complex) is located 2 kb downstream of the CpG island 94 ( Figure 7A ). We cloned this sequence of ~400 bp in a promoterless vector (PGL3basic) and cotransfected this construct along with a NF-kB p65 siRNA or a dominant active (DA) I-kBa in 293T cells. NF-kB p65 knockdown or inhibition resulted in a greater than two-fold decrease in miR-31 promoter activity, suggesting that this microRNA is transcriptionally regulated by NF-kB p65
( Figure 7D ). Sp1 is located within the CpG island of the miR-31 promoter ( Figure 7A ) and was validated through electrophoretic mobility shift assay ( Figure 7E ). These findings indicate that the putative promoter region may be bound by NF-kB transcription factor complex together with the Sp1 transcription factor.
Discussion
ESCC is a lethal cancer due to diagnosis at advanced stage and lack of effective therapies. In comparison with other human cancers, ESCCs exhibit few expression changes in microRNAs and no bona fide physiological targets. miR-31 acts as an oncomiR in ESCC (13, 14) (Figure 6 ), and tongue SCC (18) (12). Its biological functions in these cancers, however, have not been defined
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and its potential as a therapeutic target not assessed. Our rat model that recapitulates features of human ESCC, including Zn-deficiency, miR-31 overexpression, and inflammation (8, 13, 14, 42) provides an opportunity to decipher the mechanism of oncomiR-31 function in ESCC and its relationship to ESCC promotion by dietary Zn deficiency. Using this model, the current study shows that in vivo miR-31 antagonism by systemically administered LNA-anti-miR decreased miR-31 overexpression in esophagus/tongue and circulating blood and prevented the development of a preneoplastic phenotype in esophagus and tongue in ZD rats. Importantly, we show that systemic delivery of anti-miR-31 reduces cellular proliferation, activates apoptosis, and represses the miR-31 associated STK40-NF-kB based inflammation signaling in the esophagus. Thereby, the tumorigenic effects of Zn-deficiency are overcome and esophageal neoplasia inhibited. These data are the first evidence that in vivo anti-miR-31 delivery exerts multiple anticancer activities and inhibits ESCC neoplasia.
To pinpoint biologically significant miR-31 targets from the hundreds of putative targets generated by target prediction algorithms (43), our approach has led to identification of Stk40 as a biological miR-31 target by using in vivo miR-31 antagonism and microarray analysis of derepressed genes. Although Stk40 was identified as a miR-31 direct target in ovarian cancer cell lines (21) and psoriasis (34) and Stk40 is a known negative regulator of NF-kB signaling, the important connections between miR-31, Stk40, and NF-kB signaling has not been demonstrated in human cancers. Our study shows for the first time that systemic delivery of anti-miR-31 suppresses the esophageal neoplasia by derepressing its target, Stk40, and inhibiting the associated STK40-NF-kB controlled inflammatory pathway. Because the same connections among miR-31, Stk40, and NF-kB signaling is also shown in human ESCC cell lines, our in vivo results provide a mechanistic rationale for clinical development of miR-31 as a biomarker and treatment target for ESCC patients.
Transcription factors are known to regulate miRNA expression in a tissue-and disease-specific manner (44) . By performing ChIP-seq on esophagi from Zn-modulated rats using an antibody for chromatin modification mark, H3K4me3 that detects promoters (45) , our analysis identified a miR-31 promoter region activated in ZD esophagus. Dietary Zn-replenishment restored the regulation of this genomic region to the inactive state, miR-31 levels, and the hyperplastic esophageal phenotype to near normal. These data provide the first evidence that miR-31 promoter activity is regulated by dietary Zn. In addition, our motif-finding analysis demonstrates the presence of an NF-kB binding site in the miR-31 promoter region. NF-kB p65 knockdown resulted in a decrease in miR-31 promoter activity, indicative of transcriptional regulation of miR-31 by NF-kB p65.
Together, these data define a mechanism whereby Zn-deficiency upregulates miR-31 by activating its promoter/TFBs and unleashing miR-31-associated STK40-NF-kB controlled inflammatory signaling to produce a preneoplastic phenotype.
A limitation of this study is the fact that the endpoint was the early hyperplastic and inflammatory esophageal phenotype rather than esophageal cancer itself. Studies are in progress to specifically address this issue.
In summary, our in vivo work defines the signal pathway underlying the interaction of Zndeficiency and miR-31 overexpression in promoting esophageal neoplasia (Figure 8 ). OncomiR-31 is a critical target involved in ESCC pathogenesis. Antagonism of miR-31 leads to suppression of esophageal neoplasia, thereby providing support for clinical development of miR-31 as a biomarker and therapeutic target for this deadly disease. S100a8/a9 dimer protein complex, thereby promoting inflammation and cellular proliferation to produce the preneoplastic esophageal phenotype.
